Lioresal

Selected form

Baclofen

Method of action: Antispastic, Miorelaxant, Muscle Relaxant, Sedative, Skeletal Muscle Relaxant

Treatment option: Multiple Sclerosis, Spasticity, Head Injury, Crush Injury, Chronic Spasticity, Cerebral Palsy

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lioresal

Property	Description
Active ingredient	Baclofen
Form	Oral tablets, Intrathecal solution
Pharmacological class	Centrally acting skeletal muscle relaxant (Antispastic agent)
General purpose	Reduction of muscle stiffness and spasms
Origin	Synthetic compound (GABA derivative)

What Type of Medicine is Lioresal?

Lioresal is the brand name for a prescription medicine whose active ingredient is Baclofen, and it is classified as a centrally acting skeletal muscle relaxant and antispastic agent. This classification reflects its primary action on the central nervous system (CNS), specifically in the spinal cord and brain. Baclofen is a synthetic compound derived from gamma-aminobutyric acid (GABA), a naturally occurring inhibitory neurotransmitter. The modulation of nerve impulses supports its use in medicine. It is a single-ingredient monotherapy preparation.

Lioresal's Purpose and General Action

The general therapeutic purpose of Lioresal is to reduce muscle tightness and involuntary spasms associated with hyperactive nerve reflexes. It achieves this by acting as a GABAB receptor agonist, which means it modulates and inhibits excessive nerve signals that contribute to chronic muscle stiffness. Baclofen is employed for its ability to reduce the frequency and severity of muscle spasms. This mechanism provides the general benefit of relieving spasticity, such as that experienced by individuals with multiple sclerosis or spinal cord injury, which typically supports improved movement and functional capabilities.

Available Preparations: Oral and Intrathecal Forms

Lioresal is manufactured in different fundamental preparations to suit various patient needs, including standard oral tablets for systemic delivery and a sterile aqueous solution specifically engineered for intrathecal administration. The intrathecal solution is a specialized delivery system that allows Baclofen to be administered directly into the cerebrospinal fluid, enabling a highly potent, localized effect at the spinal cord for patients with severe spasticity.

Regulatory References

Baclofen - StatPearls - NCBI Bookshelf

What side effects are possible with Lioresal?

The official safety documentation for Lioresal (baclofen) classifies possible effects by frequency and system-organ class, strictly based on regulatory review of clinical trial and post-marketing data.

Adverse Reaction Scope

Classification	Examples of Documented Effects (System-Organ Class)
Very Common (ge 1/10)	Drowsiness, Sedation, Nausea, Muscle Weakness (Hypotonia) (Nervous/Musculoskeletal/GI)
Common (ge 1/100 to < 1/10)	Fatigue, Dizziness, Confusion, Insomnia, Headache, Hypotension (Nervous/Psychiatric/Vascular)

Serious Adverse Reactions and Safety Patterns

Documented serious adverse reactions primarily involve the central nervous system. A severe, clinically critical syndrome, potentially including seizures, hallucinations, high fever, and rhabdomyolysis, can occur if the medication is abruptly discontinued.

Other serious risks include respiratory depression and reported instances of suicide-related events. Effects such as drowsiness and sedation are officially noted as being more frequent at the start of treatment or if the dosage is increased too rapidly.

Population-Specific Safety Considerations

Regulatory documents include specific caution for certain groups:

Renal Impairment: The medication is largely excreted by the kidneys; patients with impaired renal function are at significantly increased risk of toxicity, including neurological symptoms like toxic encephalopathy.
Older Adults (Geriatrics): Increased susceptibility to side effects like confusion and severe drowsiness is noted, especially in combination with impaired kidney function.
Epilepsy: Baclofen may lower the convulsion threshold, requiring careful surveillance and maintenance of existing anticonvulsant therapy.

Safety-Related Restrictions: Official labeling notes that due to the potential for dizziness and sedation, the patient's capacity to drive or operate machinery may be negatively affected.

Overdose and Emergency Response

Overdose and when to seek help — Official Regulatory Information for Lioresal

The official regulatory profile for Lioresal (baclofen) overdose focuses on severe, acute manifestations that require urgent medical intervention.

Domain	Official Regulatory Statement
Documented Manifestations	Symptoms include excessive drowsiness, somnolence, confusion, nausea, vomiting, hypothermia, and seizures. Neuromuscular signs involve profound hypotonia (muscle flaccidity).
Severe Outcomes	Overdose can result in a life-threatening medical emergency, leading to acute respiratory failure, loss of consciousness progressing to coma, and cardiovascular collapse. Fatalities have been reported in cases of massive overdose.
Emergency Actions	If signs of overdose appear, the patient must be taken immediately to a hospital for assessment. Resuscitative equipment and trained staff are required to manage potentially life-threatening CNS depression and respiratory failure.

Official Overdose Statements:

Overdose is documented as being potentially life-threatening and may be sudden or insidious in onset, especially with intrathecal delivery issues.
Patients with impaired renal function are at increased risk of toxicity due to prolonged drug clearance.
Management is limited to symptomatic and supportive treatment; no specific antidote is known to reverse the effects of baclofen overdose.

Connection to the overall overdose profile: Regulatory documents define the Lioresal overdose profile by documenting severe manifestations that rapidly compromise the Central Nervous System, respiratory, and cardiovascular systems. The official profile explicitly mandates seeking immediate medical attention and hospital-based supportive care to manage these severe risks, particularly for securing the airway and maintaining hemodynamic stability, as there is no specific pharmaceutical agent available to reverse the drug's effects.

Therapeutic Uses of Lioresal

Lioresal (baclofen) is commonly used in the therapeutic domains involving the management of increased muscle tone and excessive muscle activity. It is often applied in addressing spasticity, and is often applied during phases when symptoms related to heightened physiological activity become more noticeable, commonly associated with chronic conditions affecting functional stability.

The medication is considered relevant for easing symptom clusters that may become intense or disruptive, such as involuntary muscle spasms, cramping, and noticeable physiological strain. It is commonly used across conditions presenting with acute episodes, such as spasticity in multiple sclerosis, conditions linked to organ-specific functional stress in the spinal cord (including tumors or trauma), and spasticity of cerebral origin (for example, following strokes or in cerebral palsy). This supportive approach is relevant when supportive symptom management is appropriate, and may assist with maintaining functional stability when symptoms interfere with routine activities. The support provided by this medication helps patients cope more steadily with symptom fluctuations.

“This medication is applied in addressing situations where additional management of discomfort is required due to heightened systemic burden.”

Quick Fact: Supports management of symptoms of increased neurological or muscular activity

Eligibility and Restrictions for Use

Lioresal (baclofen) eligibility is governed by official restrictions related to patient status, age, and co-existing medical conditions, as defined in regulatory labeling.

Contraindications and Restrictions

The medicine is contraindicated for patients with a known hypersensitivity to baclofen or any other component of the formulation [Source 1.5, 2.5]. It is also not indicated for muscle spasm caused by rheumatic disorders [Source 1.7, 1.10].

Age and Weight Limits:

Population	Regulatory Status	Constraint
Pediatric	Not established/Not suitable	Safety and efficacy are not established for children younger than 12 years (tablets); tablets are not suitable for children weighing below 33 kg [Source 1.1, 1.3].
Geriatric	Conditional use	Requires a cautious dosage schedule and careful surveillance due to increased susceptibility to side effects [Source 1.1, 2.1].

Condition-Based Cautions (Use with Surveillance):

Special caution and close monitoring are required for patients with: impaired renal function (mandating particularly low doses), epilepsy or seizure history, psychotic disorders, Parkinson's disease, cerebrovascular diseases (e.g., stroke), and hepatic impairment [Source 1.3, 1.9, 2.8].

Pregnancy and Lactation:

Use during pregnancy is conditional; it is only permitted if the potential benefit justifies the potential risk to the fetus, with a risk of neonatal withdrawal syndrome noted [Source 1.7, 1.9]. During lactation, use requires weighing potential benefits against risks to the infant, as the substance is secreted in breast milk [Source 1.8].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Lioresal (baclofen) primarily through pharmacodynamic and pharmacokinetic considerations. There are currently no drug-drug combinations formally classified as contraindicated in primary prescribing information.

Documented Interaction Patterns

Interaction Type	Interacting Substances/Categories	Regulatory Outcome Description
Additive CNS Depression	Alcohol and other CNS depressants (e.g., opioids, benzodiazepines, tizanidine)	Co-administration may result in increased sedation, drowsiness, and elevated risk of respiratory depression.
Pharmacodynamic Reinforcement	Tricyclic Antidepressants, Levodopa/Carbidopa	May cause pronounced muscular hypotonia or lead to adverse central nervous system outcomes like agitation or mental confusion.
Additive Hypotension	Antihypertensives	Use is likely to increase the fall in blood pressure due to an additive effect.
Altered Drug Exposure	Agents reducing renal function (e.g., NSAIDs)	These substances may reduce baclofen excretion leading to increased plasma levels and risk of toxic effects.

Population-Specific Constraints

The interaction profile is significantly impacted by renal function. Because baclofen is mainly excreted unchanged by the kidneys, its effects may be increased in patients with kidney disease due to slower removal from the body, leading to a risk of elevated plasma concentrations.

Mechanism of Action

Baclofen initiates its physiological effect by acting as an agonist at the GABA-B receptor (Gamma-aminobutyric acid type B), a primary inhibitory target within the central nervous system. Its mechanism focuses dominantly on dampening nerve signaling at the spinal cord level.

Targeting GABA-B Receptors and Initiating Hyperpolarization

The drug's primary action involves binding to and activating the GABA-B receptor, which is a G-protein-coupled receptor. This activation triggers an internal cascade that causes potassium ion ( K+) channels to open and calcium ion ( Ca2+) channels to close. The resulting efflux of K+ ions causes neuronal hyperpolarization, which reduces the nerve cells' excitability.

Suppressing Excitatory Neurotransmission and Spinal Reflexes

By inhibiting Ca2+ influx, the drug effectively reduces the release of excitatory neurotransmitters—primarily glutamate—from presynaptic nerve terminals. This two-pronged action (hyperpolarization and reduced transmitter release) leads to the inhibition of both monosynaptic and polysynaptic reflex arcs in the spinal cord. The physiological consequence is a reduction in the signal transmission through the reflex arc, thereby lowering the hyperexcitability of motoneurons.

Dosage and Administration Information

How to Use Lioresal

Lioresal (baclofen) is administered through two distinct official routes: oral tablets for systemic use or a sterile solution for specialized intrathecal administration via an implantable pump. The method of use is governed by protocols that define dosing, frequency, and administration context.

Official Administration Protocols

Entity	Official Use
Dosing Initiation	Oral: Starts low, typically 15 mg daily or 5 mg three times daily (t.i.d.), with dose increases made gradually at prescribed intervals (e.g., every 3 days). Intrathecal: Requires an initial screening test bolus, typically 50 mcg, followed by chronic infusion if successful.
Maintenance Dose	Oral: Generally ranges from 30 mg to 80 mg daily, administered in divided doses. Intrathecal: Administered via continuous infusion; dose ranges vary by origin of spasticity.
Intake Timing	Oral tablets should be taken during meals with a small amount of liquid.
Special Conditions	The intrathecal route is reserved for patients who do not respond to oral therapy or experience intolerable side effects. Initial intrathecal screening and dose adjustments must be performed in a medically supervised hospital setting.
Population Rules	Renal Impairment: Requires a particularly low starting dose (e.g., 5 mg daily). Pediatric: Dosing is weight-based (e.g., 0.3 mg/kg daily starting dose).

Discontinuation Protocol

Treatment with Lioresal must never be stopped abruptly. Standard instructions mandate that cessation must be a gradual process achieved by slowly reducing the dosage over a period of approximately one to two weeks. For oral treatment, discontinuation should be considered if no therapeutic benefit is observed after six to eight weeks at the maximum recommended dose.

Recent Clinical Evidence

Lioresal: Recent Clinical Evidence

Lioresal (baclofen) is a muscle relaxant and antispastic agent. Its primary established use is for the treatment of spasticity arising from multiple sclerosis, spinal cord injuries, or other spinal cord disorders.

Investigational Use and Research Focus

Recent clinical research on baclofen has primarily centered on alternative delivery methods and its potential role in treating conditions beyond spasticity, reflecting an ongoing effort to optimize treatment and understand its pharmacological scope.

Research has evaluated the use of baclofen in adult patients with spinal spasticity and cerebral spasticity. Studies have also explored its effect in reducing symptoms associated with chronic pain.

Research Area	Focus of Evaluation
Chronic Pain	Investigating the drug's relationship to pain scores in conditions with spasticity
Delivery Systems	Comparing the efficacy and safety profile of oral versus intrathecal administration

Key Findings on Intrathecal Administration

The intrathecal route, which delivers baclofen directly into the cerebrospinal fluid, is typically reserved for severe, refractory spasticity. Studies examining this delivery system have focused on establishing optimal dosing and minimizing side effects.

Clinical trials have assessed the need for dose adjustments in patients receiving continuous intrathecal infusion.
Studies have measured motor function scales and patient-reported outcomes to quantify changes in muscle tone and symptom severity.

Research on Off-Label Conditions

A separate body of research has explored the relationship between baclofen and alcohol dependence, although this use remains off-label. Research has also investigated whether baclofen is related to the frequency and severity of certain tremor conditions.

Key Studies & References

NICE Guideline NG194: Spasticity in children and young people: management

Frequently Asked Questions (FAQ)

Common questions about Lioresal (FAQ)

Q: Is Lioresal considered a pain reliever?

Lioresal is approved to treat spasticity—severe muscle tightness and stiffness. While official product information mentions it may help relieve pain that is a direct result of muscle spasms (referred to as concomitant pain), it is not formally classified as a general pain reliever or analgesic.

Q: Is Lioresal used for chronic back pain?

Lioresal is indicated for spasticity resulting from conditions like multiple sclerosis or spinal cord disorders. Regulatory information indicates its approved use is specifically for spasticity and associated symptoms, not for the treatment of general chronic back pain.

Q: What does Lioresal treat besides spasticity?

Official documentation indicates that the primary established indication for Lioresal is the alleviation of the signs and symptoms of spasticity. Uses outside of this indication are considered investigational and are not part of the standard approved regulatory label.

Q: Does Lioresal impact mood or cause depression?

Yes, official regulatory documents list several central nervous system effects. Adverse reactions that have been reported include changes in mood such as depression, a confusional state, and a euphoric mood.

Q: Do the side effects of Lioresal usually go away over time?

Official product information notes that some common effects, such as drowsiness and sedation, are reported as being more frequent at the start of treatment or when the dose is increased. This specific documentation on initial frequency does not cover all possible side effects.

Q: Is Lioresal used for cerebral palsy?

Lioresal is used to treat spasticity that arises from various causes, including cerebral spasticity (muscle stiffness related to the brain). Its use is directed specifically at treating the muscle stiffness and spasms associated with various neurological conditions.

Q: Does Lioresal need to be taken at the same time every day?

The regulatory documents describe the typical use as being taken in divided doses at evenly spaced intervals throughout the day. This schedule is intended to help maintain consistent levels of the medicine in the body.

Q: Is Lioresal safe for long-term use?

Official documentation states that abrupt cessation of the drug after prolonged use carries a risk of severe withdrawal symptoms, such as seizures or hallucinations. This core warning highlights the risk of physical dependence associated with continuous use.

Q: What happens if I forget a dose of Lioresal?

Official patient information describes the procedure: taking the missed dose as soon as remembered. If it is almost time for the next scheduled dose, regulatory information advises skipping the missed dose and resuming the regular schedule. Regulatory information advises against taking a double dose to compensate for the missed one.

Q: Is Lioresal a controlled substance?

No, Lioresal (baclofen) is not currently classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or similar regulatory bodies.

Q: What should I do if I experience a severe side effect from Lioresal?

Official patient information advises that seeking emergency medical assistance is necessary if serious or sudden symptoms occur, such as seizures, profound confusion, difficulty breathing, or complete muscle weakness. These symptoms can indicate a serious adverse reaction or an overdose.

Q: What is the average duration of treatment with Lioresal?

Official product information does not define a standard average duration for all patients, as the length of treatment depends on the individual condition. Some patient literature indicates Lioresal may need to be taken for a long time to effectively control chronic muscle spasms.

Q: What happens if I take too much Lioresal?

Taking too much Lioresal can lead to overdose symptoms detailed in the official label, which include profound drowsiness, vomiting, muscular hypotonia (muscle weakness), and vision problems. Severe overdose can result in respiratory depression (slowed breathing) and seizures.

Q: Can Lioresal be crushed or split?

Regulatory guidance suggests only splitting tablets if they are officially scored (designed with a line for splitting). Regulatory guidance describes consulting a healthcare professional before altering the tablet to ensure proper dosing.

Q: What are the signs of an allergic reaction to Lioresal?

Official patient information indicates that signs of a serious allergic reaction may include hives or skin rash, itching, and swelling of the face, lips, tongue, or throat. Official information advises that if these signs appear, emergency medical assistance should be sought.

Q: Does Lioresal cause weight changes?

Official regulatory documents list weight gain as a reported adverse reaction. Weight loss has also been reported as an uncommon side effect.

Q: Is Lioresal associated with vision problems?

Yes, vision problems are listed as possible side effects. Reported adverse reactions include visual impairment, blurred vision, difficulty focusing (accommodation disorder), double vision (diplopia), and nystagmus (involuntary eye movement).

Q: Are there different strengths of Lioresal tablets available?

Yes, the official label confirms that oral baclofen tablets are generally supplied in several strengths, such as 5 mg, 10 mg, and 20 mg. This allows for the prescribed dose to be tailored to the individual's needs.

How should Lioresal be stored and disposed of?

How to Store and Dispose of Lioresal

Official storage and disposal instructions for Lioresal (baclofen) differ based on the product form. All forms must be kept out of the sight and reach of children.

Storage Requirements by Form

Form	Temperature Requirement	Protection/Handling Rule
Oral Tablets	Store below 30 C (86 F)	Keep in the original package to protect from moisture
Intrathecal Solution	Store at Controlled Room Temperature (20 C to 25 C)	Do not freeze; single use only; discard unused portion

Disposal

Expired or unused Lioresal must not be thrown away via wastewater or regular household trash. Disposal must occur according to local requirements and protocols, such as using authorized drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.